Limited evidence indicates that breastfeeding after cessation of long-term bisphosphonate treatment appears to have no adverse effects on the infant. Because no information is available on the use of alendronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of alendronate by a breastfed infant is unlikely. If the mother receives a bisphosphonate during pregnancy or nursing, some experts recommend monitoring the infant's serum calcium during the first 2 months postpartum.[1]
有限的证据表明，长期双膦酸盐治疗停止后进行母乳喂养似乎对婴儿没有不良影响。由于没有关于哺乳期使用阿仑膦酸盐的信息，可能更倾向于选择其他药物，尤其是在哺育新生儿或早产儿期间。然而，母乳喂养的婴儿不太可能吸收阿仑膦酸盐。如果母亲在怀孕或哺乳期间接受双膦酸盐治疗，一些专家建议在产后头2个月监测婴儿的血清钙。[1]
